Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC
Clinical trial NCT06153368 · UNKNOWN
Trial details
- NCT number
- NCT06153368
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-11-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.